Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31
Published November 28, 2018 · Recall initiated: November 7, 2018
Summary
FDA records drug Class II recall D-0283-2019, published November 28, 2018 and initiated November 7, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 4,212 (30-count blister pack); Lot: Lot #: T600530, Exp 11/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if CLOPIDOGREL BISULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLOPIDOGREL BISULFATE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- U.S.A.nationwide
- Lot
- Lot #: T600530, Exp 11/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr.December 19, 2018
- FDAEqui-Soft Foam, Antimicrobial Hand Soap, 0.55% Benzalkonium Chloride, 25 fl oz (750 mL), OTC, Ecolab, 370November 28, 2018
- FDARoasted Corn Salsa; Net Weight: 10 lbs. (10 x 1 lb. bags) Corner Bakery Caf® Brand Ingredients: Corn, RedNovember 28, 2018
- FDAGSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDCNovember 28, 2018
- FDACadence Gourmet Balsamic Roasted Vegetables; Net Weight: 10 lbs. (4.5 kg)/ cs UPC: 00851124006382 Ingredients:November 28, 2018
- FDAGSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDCNovember 28, 2018
Questions about this recall
Was Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31 recalled?
Yes. FDA published recall D-0283-2019 on November 28, 2018. Reported hazard: Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLOPIDOGREL BISULFATE.